Marinus Pharmaceuticals Inc MRNS Balance Sheet

Income Statement

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	259.52M	226.82M	201.2M	200.81M	170.91M	137.35M	87.08M	63.62M
Total Current Assets	252.38M	220M	194.61M	195.04M	165.25M	131.28M	81.88M	57.4M
Cash and Equivalents	240.55M	146.9M	127.79M	140.44M	120.57M	104.25M	64.68M	42.18M
Total Non-Current Assets	11.38M	6.82M	6.59M	5.77M	9.51M	6.07M	5.2M	6.22M
Total Liabilities	143.52M	141.73M	143.86M	146.27M	154.14M	153.78M	134.43M	130.36M
Total Current Liabilities	25.02M	21.51M	25.6M	30.56M	40.62M	42.76M	35.87M	34.5M
Total Non-Current Liabilities	189.52M	191.72M	186.39M	180.5M	174.94M	169.1M	143.64M	137.57M
Common Equity	4.09M	4.09M	51k	55k	55k	55k	55k	55k
Retained Earnings	-430.52M	-465.25M	-497.19M	-530.16M	-571.93M	-610.6M	-646.42M	-670.65M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	31.45M	60.67M	75.23M	98.84M	150.46M	136.84M	259.52M	170.91M
Total Current Assets	30.3M	54.37M	73.94M	94.13M	146.27M	131.68M	252.38M	165.25M
Cash and Equivalents	26.18M	33.53M	67.73M	90.94M	138.51M	122.93M	240.55M	120.57M
Total Non-Current Assets	21.48M	58.01M	68.33M	59.57M	137.2M	53.49M	116M	16.77M
Total Liabilities	9.97M	2.66M	6.91M	11.07M	13.26M	83.35M	143.52M	154.14M
Total Current Liabilities	8.08M	2.54M	6.91M	8.03M	10.73M	40.57M	25.02M	40.62M
Total Non-Current Liabilities	3.63M	120k	0	3.04M	2.53M	83.6M	189.52M	174.94M
Total Equity	21.48M	58.01M	68.33M	59.57M	137.2M	53.49M	116M	16.77M
Common Equity	20k	41k	53k	87k	4.51M	4.34M	4.09M	55k
Retained Earnings	-125.83M	-144.73M	-181.45M	-235.57M	-311.93M	-410.71M	-430.52M	-571.93M